Mycophenolate mofetil as an adjuvant therapy for classic and endemic pemphigus foliaceus

Journal of Dermatology

Volumn 32, Issue 7, 2005, Pages 574-580

  Kawashita, Milka Yuri ^a   Tsai, Katia ^a   Aoki, Valéria ^a   Santi, Claudia Giuli ^a   Maruta, Celina Wakisaka ^a   Rivitti, Evandro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Fogo selvagem; IgG subclass; Immunosupression; Mycophenolate mofetil; Pemphigus foliaceus

Indexed keywords

AZATHIOPRINE; COMPLEMENT COMPONENT C3; CORTICOSTEROID; DESMOGLEIN 1; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G4; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIAMCINOLONE;

ACANTHOLYSIS; ADJUVANT THERAPY; ADULT; ARTICLE; AUTOIMMUNE DISEASE; BRAZIL; CASE REPORT; CORTICOSTEROID THERAPY; CUSHINGOID SYNDROME; DRUG EFFICACY; DRUG TOLERABILITY; ENDEMIC DISEASE; FEMALE; HERPES SIMPLEX; HUMAN; HYPERTENSION; IMMUNOFLUORESCENCE; MALE; MYOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPENIA; OSTEOPOROSIS; PEMPHIGUS FOLIACEUS; REMISSION; SEPSIS; SKIN ABSCESS; THRUSH; VERTEBRA FRACTURE;

EID: 23944524537     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2005.tb00801.x     Document Type: Article

References (36)

1. Dias LA, Sampaio SAP, Rivitti EA, et al: Endemic pemphigus foliaceus (fogo seivagem). I. Clinical features and immunopathology, J Am Acad Dermatol, 20: 657-669, 1989.
2. Aoki V, Millikan RC, Rivitti EA, et al: Enviromental risk factors in endemic pemphigus foliaceus (fogo seivagem), J Investig Dermatol Sump Proc, 9: 34-40, 2004.
3. Aoki V, Huang MHT, Périgo AM, et al: Endemic pemphigus foliaceus (fogo seivagem) and pemphigus vulgaris: Immunoglobulin G heterogeneity detected by indirect immunofluorescence, Rev Hosp Clin Fac Med S Paulo, 59: 251-256, 2004.
4. Stanley JR: Pemphigus, in Freedberg IM, Eisen AZ, Wolff K, et al (eds): Fitzpatrick's Dermatology in General Medicine, McGraw-Hill, New York, 2003, pp 558-567.
5. Beutner EH, Pringenzi LS, Hale W, Lerne CA, Bier OG: Immunofluorescent studies of autoantibodies to intercellular areas of epithelia in Brazilian pemphigus foliaceus, Proc Soc Exp Biol Med, 127: 81-86, 1968.
6. Anhalt GJ, Labib RS, Woorhess JJ, Beals TF, Dias LA: Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease, N Engl J Med, 306: 1189-1196, 1982.
7. Roscoe JT, Diaz LA, Sampaio SAP, et al: Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB/c mice by passive transfer, J Invest Dermatol, 85: 538-541, 1985.
8. Hacker MK, Janson M, Fairley JA, Lin MS: Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies, Clin Immunol, 105: 64-74, 2002.
9. Rock B, Martins CR, Theofilopoulos AN, et al: The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem), N Engl J Med, 320: 1463-1469, 1989.
10. Warren SJP, Arteaga LA, Rivitti EA, et al: The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus, J Invest Dermatol, 120: 1-5, 2003.
11. David M, Katzenelson V, Hazaz B, Ben-Chetrit A, Sandbank M: Determination of IgG subclasses in patients with pemphigus with active disease and in remission, Arch Dermatol, 125: 787-790, 1989.
12. Ahmed AR, Moy R: Death in pemphigus, J Am Acad Dermatol, 7: 221-228, 1982.
13. Seidenbaum M, David M, Sandbank M: The course and prognosis of pemphigus, Int J Dermatol, 27: 580-584, 1988.
14. Bystryn J, Steinman N: The adjuvant therapy of pemphigus, Arch Dermatol, 132: 203-212, 1996.
15. Enk AH, Knop J: Treatment of pemphigus vulgaris with mycophenolate mofetil, Lancet, 350: 494, 1997.
16. Enk AH, Knop J: Mycophenolate is effective in the treatment of pemphigus vulgaris, Arch Dermatol, 135: 54-56, 1999.
17. Grundmann-Kollman M, Kaskel P, Leiter U, et al: Treatment of pemphigus vulgaris and bullous pemphigoid with mycophenolate mofetil monotherapy, Arch Dermatol, 135: 724-725, 1999.
18. Grundmann-Kollmann M, Korting HC, Behrens S, et al: Mycophenolate mofetil: A new therapeutic option in the treatment of blistering autoimmune diseases, J Am Acad Dermatol, 40: 957-960, 1999.
19. Katz KH, Marks Jr JG, Helm KF: Pemphigus foliaceus successfully treated with mycophenolate mofetil as a steroid-sparing agent, J Am Acad Dermatol, 42: 514-515, 2000.
20. Chams-Davatchi C, Azar RN, Daneshpazoo M, et al: Etude ouverte du mycophénolate mofetil dans le traitement du pemphigus résistant. Ann Dermatol Venereol, 129: 23-35, 2002.
21. Mimouni D, Anhalt GJ, Cummins DL, Kouba DJ, Thorne JE, Nousari C: Treatment of pemphigus vulgaris and pemphigus foliaceus with mycophenolate mofetil, Arch Dermatol, 139: 739-742, 2003.
22. Powell AM, Albert S, Fares SAL, et al: An evaluation of the usefulness of mycophenolate mofetil in pemphigus, Br J Dermatol, 149: 138-145, 2003.
23. Lynch WS, Roenigk HH: Mycophenolic acid for psoriasis, Arch Dermatol, 113: 1203-1208, 1987.
24. Lipsky JJ: Mycophenolate mofetil, Lancet, 348: 1357-1359, 1996.
25. Epinette WW, Parker CM, Jones EL, Greist MC: Mycophenolic acid for psoriasis, J Am Acad Dermatol, 17: 962-971, 1987.
26. Gray DW: Mycophenolate mofetil for transplantation: New drug, old problem?, Lancet, 350: 494, 1997.
27. Nousari HC, Griffin WA, Anhalt GJ: Successful therapy for bullous pemphigoid with mycophenolate mofetil, J Am Acad Dermatol, 39: 497-498, 1998.
28. Nousari HC, Sragovich A, Kimyai-Asadi A, Orlinsky D, Anhalt GJ: Mycophenolate mofetil in autoimmune and inflammatory skin disorders, J Am Acad Dermatol, 40: 265-268, 1999.
29. Rivitti EA, Camargo ME, Castro RM, Sampaio SAP: Use of methotrexate to treat pemphigus foliaceus, Int J Dermal, 12: 119-122, 1973.
30. Auad A, Castro RM, Fraga S, et al: The treatment of Brazilian pemphigus foliaceus, Int J Dermatol, 2: 130-136, 1970.
31. Goldblum R: Therapy of rheumatoid arthritis with mycophenolate mofetil, Clin Exp Rheumatol, 11: s117-119, 1993.
32. Kitchin EJS, Pomeranz MK, Pak G, Washenik K, Shupak JL: Rediscovering mycophenolic acid: a review of its mechanism, side effects, and potential uses, J Am Acad Dermatol, 37: 445-449, 1997.
33. Sami N, Bhol KC, Ahmed AR: Diagnostic features of pemphigus vulgaris in patients with pemphigus foliaceus: Detection of both autoantibodies, long-term follow-up and treatment responses, Clin Exp Immunol, 125: 492-498, 2001.
34. Pegas JRP: Effects of immunofluorescence on healthy skin, injured skin and the tissue around injury and indirect immunofluorescence in patients with endemic pemphigus foliaceus (fogo selvagem). São Paulo, 1999. 114p. Dissertação (Mestrado)-Faculdade de Medicina, Universidade de São Paulo.
35. Rivitti EA: Eletroforese, imunoeletroforese, antiestreptolisina e anticorpos antiepitélio no pẽnfigo foliáceo sul-americano. Estudo evolutivo. São Paulo, 1972. 105p. Dissertação (Doutorado)-Faculdade de Medicina, Universidade de São Paulo).
36. Li N, Aoki V, Hans-Filho G, et al: The role of intramolecular epitope spreading in the pathogenesis of endemic pemphigus foliaceus (fogo selvagem), J Exp Med, 197: 1501-1510, 2003.